Thank you to all who supported CHI's Ninth Annual Discovery on Target event!

Over 500 participants gathered at the historic Park Plaza Hotel & Towers in Boston, Massachusetts CHI's Discovery on Target event. From attendees, to exhibitors, speakers, and sponsors this year's conference was another great success for all involved.

Delegates enjoyed being able to create their own agenda by moving between the tracks and choosing the sessions that best fit their learning and networking needs.

The Exhibit Hall functions offered ample networking opportunities, and the perfect venue to launch new product and services.

Plan to join us again next year October 1-3, 2012 in Boston!

If you would like to share your feedback, or give input for next year's event please contact, Margit Eder at

November 2-3 

HDAC Inhibitors

GPCR-Based Drug Discovery

The Kinase Inhibitor Pipeline

Cancer Cell Metabolism 

November 3-4 

RNAi for Functional Screens

Allosteric Modulators

Targeting the P13K Pathway

Diabetes Drug Discovery 


● Co-Located: Ion Channel Symposium
● 130+ Scientific and Technical Presentations
● 500+ Participants
● Breakout Discussion Groups

● 30+ Exhibiting Companies
● 9 Interactive Short Courses
● Dedicated Poster Viewing

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

2014 Discovery on Target Brochure  

 green arrow FINAL BROCHURE 



green arrow VIEW ALL SPONSORS 



The exhibit hall was sold out in 2013, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2014, contact:

Jon Stroup
Business Development Manager

2014 Discovery On Target CAG 



October 8 – 9

Targeting Epigenetic Readers and
Chromatin Remodelers

Targeting the Ubiquitin Proteasome System  

Big Data Analytics and Solutions  

GPCR-Based Drug Discovery  

RNAi for Functional Genomics Screening
– Part 1

Protein-Protein Interactions as Drug Targets  

Antibodies Against Membrane Protein Targets
– Part 1

October 9 – 10

Targeting Histone Methyltransferases and Demethylases  

Screening Drug Transporter Proteins  

Maximizing Efficiency in Discovery  

GPCR-Targeted Therapeutics  

Genome Editing for Functional Genomics
Screens – Part 2

Cancer Metabolism  

Antibodies Against Membrane Protein Targets
– Part 2


October 7

Next Generation Histone Deacetylase Inhibitors  


October 7

SC1: Designing Scalable Software Systems for Big Data Analytics  

SC2: Approaches for Biologically-Relevant Chemical Diversity  

SC3: Setting Up Effective RNAi Screens: From Design to Data to Validation  

SC4: Targeting Protein-Protein Interactions  

SC5: GPCR Structure-Based Drug Discovery  

SC6: Advances in Metagenomic Drug Discovery for New Anti-Infective Agents  

SC7: Targeting of GPCRs with Monoclonal Antibodies  

SC8: A Primer to Gene Editing: Tools and Applications  

SC9: Introduction to Targeted Covalent Inhibitors  

October 9

SC10: Setting Up Effective Functional Screens Using 3D Cell Cultures  

SC11: Integration of BDDCS and Extended Clearance Principles  

SC12: Introduction to Allosteric Modulators and Biased Ligands of GPCRs  

SC13: Introduction to Drug Metabolism